A news item in Genomeweb today notes that Personal Genome Diagnostics, a Baltimore-based lab stemming out of Johns Hopkins, has newly licensed IP regarding Total Mutational Burden (TMB) from Memorial Sloan Kettering Cancer Center (MSKCC). Earlier, it had licensed MSI IP from Johns Hopkins.
The "aha" moment for me was that there is IP to license in commonly discussed areas like TMB and MSI. Given the evolving legal climate for diagnostic patents in recent years, from Supreme Court down, it must be an intriguing area for molecular IP attorneys.
PGD raised $21M in 2016. This week, there are 40 papers on Pubmed discussing TMB and 7045 on "microsatellite instability."